What is the appropriate dosing regimen for a transdermal nitroglycerin (glyceryl trinitrate) patch delivering 0.2–0.4 mg per hour for the treatment of tendinitis?

Nitroglycerin Patch Dosing for Tendinitis

Apply a transdermal nitroglycerin patch delivering 1.25 mg per 24 hours (achieved by cutting a standard 5 mg/24h patch into quarters) to the site of maximal tenderness, replacing it daily for 12–24 weeks, combined with eccentric strengthening exercises and activity modification.

Evidence-Based Dosing Protocol

Patch Preparation and Application

• Cut a standard 5 mg/24h nitroglycerin patch into quarters to deliver approximately 1.25 mg per 24 hours—the dose validated in multiple tendinopathy trials 1, 2.
• Apply one quarter-patch daily to the area of maximal tenderness over the affected tendon 2.
• Replace the patch every 24 hours at the same time each day 1, 2.
• The 0.2–0.4 mg/h patches mentioned in your question deliver 4.8–9.6 mg per 24 hours, which exceeds the evidence-based dose; use the quarter-patch method instead 1, 2.

Treatment Duration

• Continue daily application for 24 weeks (6 months) to achieve maximal benefit 1, 2.
• Significant pain reduction typically appears at 12 weeks, with further improvement through 24 weeks 1, 2.
• One study using only 3 days of treatment in shoulder tendinitis showed benefit, but chronic tendinopathies require prolonged therapy 3.

Mandatory Concurrent Rehabilitation

• Eccentric strengthening exercises are essential—nitroglycerin alone without rehabilitation shows no benefit 4.
• Begin a structured 12-week eccentric exercise program targeting the affected musculotendinous unit 2, 4.
• Implement activity modification and rest from aggravating movements 2.
• Use heel-raise wedges (for Achilles tendinopathy) or appropriate biomechanical aids 2.
• Perform prolonged daily stretching of the involved muscle groups 2.

Clinical Efficacy by Outcome

Pain Reduction

• Nitroglycerin significantly reduces pain with activity at 12 weeks (mean difference 0.7 points on 0–4 scale, p=0.02) and 24 weeks (mean difference 0.6 points, p=0.03) 1, 2.
• Night pain decreases significantly at 12 weeks (mean difference 0.5 points, p=0.04) 1.
• Local tenderness improves at 12 weeks (mean difference 0.7 points, p=0.02) 1.
• Meta-analysis shows nitroglycerin increases the odds of pain relief during daily activities 4.44-fold (95% CI 2.34–8.40) 5.

Functional Outcomes

• 78% of tendons become asymptomatic with activities of daily living at 6 months, compared to 49% with placebo (p=0.001) 1.
• Pain after single-leg hop testing decreases significantly at 24 weeks (mean difference 1.1 points, p=0.005) 1.
• Ankle plantar flexor work increases compared to baseline at 24 weeks (p=0.04) 1.

Outcomes That Do NOT Improve

• Pain at rest shows conflicting evidence and may not improve 5, 2.
• Pain duration and sleep hours do not change significantly 5.
• One high-quality 2024 trial found no benefit when adding nitroglycerin to eccentric exercises for Achilles tendinopathy, suggesting the evidence remains mixed 4.

Absolute Contraindications

Recent Phosphodiesterase-5 Inhibitor Use

• Do not apply nitroglycerin within 24 hours of sildenafil or vardenafil 6, 7.
• Do not apply within 48 hours of tadalafil 6, 7.
• Concurrent use can cause profound hypotension, myocardial infarction, or death through excessive cGMP-mediated vasodilation 7.

Cardiovascular Contraindications

• Systolic blood pressure < 90 mmHg 6, 7.
• Severe bradycardia (< 50 bpm) or tachycardia (> 100 bpm) 6, 7.
• Suspected right-ventricular infarction 6, 7.
• Volume depletion or severe anemia 6, 7.

Other Contraindications

• Increased intracranial pressure 8.
• Known hypersensitivity to nitroglycerin 8.
• Current pregnancy or breastfeeding unless specifically prescribed 8.

Expected Side Effects and Management

Headache (Most Common)

• Occurs in 53% of patients receiving nitroglycerin versus 45% with placebo 2.
• Typically mild to moderate and resolves with continued use 1, 2.
• Manage with 500 mg acetaminophen as needed 2.
• Headache causes treatment discontinuation in 1–9 patients per study 5.

Contact Dermatitis

• Occurs in 16% of nitroglycerin users versus 12% with placebo 2.
• Rotate patch application site daily to minimize skin irritation 2.
• No difference in dermatitis rates between nitroglycerin and placebo in pooled data 5.

Cardiovascular Effects

• Postural hypotension may occur; advise patients to rise slowly from sitting or lying 8.
• Reflex tachycardia can develop as a compensatory response to vasodilation 8.
• Monitor blood pressure if patients report dizziness or lightheadedness 8.

Practical Algorithm for Implementation

Step 1: Verify Eligibility

• Confirm chronic tendinopathy (symptoms > 3 months) with clinical examination and ultrasound 2.
• Exclude tendon tears, fractures, dislocations, or referred pain from cervical radiculopathy 2, 9.
• Check for recent PDE-5 inhibitor use (within 24–48 hours) 6, 7.
• Measure baseline blood pressure and ensure systolic ≥ 90 mmHg 6, 7.

Step 2: Initiate Treatment

• Provide a 5 mg/24h nitroglycerin patch and instruct the patient to cut it into quarters 2.
• Apply one quarter-patch to the most tender point on the affected tendon 2.
• Replace daily at the same time, removing the old patch before applying the new one 2.
• Prescribe acetaminophen 500 mg for headache management 2.

Step 3: Begin Concurrent Rehabilitation

• Start a 12-week eccentric exercise program specific to the affected tendon 2, 4.
• Implement activity modification and rest from aggravating movements 2.
• Teach daily prolonged stretching of the involved muscle groups 2.
• Provide biomechanical aids (e.g., heel wedges for Achilles tendinopathy) 2.

Step 4: Monitor Progress

• Assess pain, function, and side effects at 6,12, and 24 weeks 1, 2.
• Expect significant improvement at 12 weeks, with further gains through 24 weeks 1, 2.
• If headache is intolerable despite acetaminophen, consider discontinuation 5, 2.

Step 5: Discontinuation

• After 24 weeks, discontinue the patch 1, 2.
• Continue eccentric exercises and activity modification indefinitely 2, 4.
• One study showed no long-term benefit at 5 years, suggesting maintenance therapy may be needed 9.

Critical Pitfalls to Avoid

Using Incorrect Patch Strength

• Do not use 0.2–0.4 mg/h patches as suggested in your question—these deliver 4.8–9.6 mg per 24 hours, far exceeding the validated 1.25 mg dose 1, 2.
• The evidence supports 1.25 mg per 24 hours, achieved by quartering a 5 mg/24h patch 1, 2.

Omitting Eccentric Exercises

• Nitroglycerin without rehabilitation is ineffective—the 2024 NEAT trial showed no benefit when exercises were not optimized 4.
• Always combine nitroglycerin with a structured eccentric strengthening program 2, 4.

Premature Discontinuation

• Significant benefit requires 12–24 weeks of continuous use 1, 2.
• Do not stop at 3 days (as in one shoulder study) for chronic tendinopathies 3.

Ignoring PDE-5 Inhibitor Interactions

• This is the most dangerous drug interaction—always screen for recent sildenafil, vardenafil, or tadalafil use 6, 7.
• Concurrent use can be fatal 7.

Applying to Broken Skin

• Do not apply patches to abraded or irritated skin—rotate application sites daily 2.

Evidence Strength and Limitations

• The evidence for nitroglycerin in tendinopathy is moderate quality, with multiple randomized controlled trials showing benefit 3, 5, 1, 2.
• However, the 2024 NEAT trial found no benefit, suggesting the effect may depend on optimal rehabilitation protocols 4.
• The 2024 Achilles Tendinopathy Clinical Practice Guideline does not strongly endorse nitroglycerin, reflecting ongoing uncertainty 10.
• Long-term benefit beyond 6 months is unproven—one 5-year follow-up showed no sustained effect 9.
• Most studies used Achilles or lateral epicondyle tendinopathy; evidence for other tendons is limited 3, 5, 1, 2, 9.

3, 5, 1, 2, 4, 10, 9